联合健康 UNH
关于
联合健康(UnitedHealth)运营美国最大的健康保险公司UnitedHealthcare,以及Optum健康服务和药品福利部门。
通常是什么在影响股价
Medicare Advantage业务的医疗成本、政府调查,以及公司的复苏计划,是主要问题。
人均创收
截至2025/FY,员工人数为390,000(同比-2.5%)。人均创收为总营收除以员工人数——是粗略的生产效率指标,不是员工薪酬数字。
管理团队
Tim Noel has served as Chief Executive Officer of UnitedHealthcare since January 2025. Previously, Tim served as Chief Executive Officer of UnitedHealthcare's Medicare & Retirement business and held numerous leadership roles since joining UnitedHealth Group from 2007 until January 2025, including serving as Chief Financial Officer and Senior Vice President of federal products for Medicare & Retirement.
Dr. Patrick Conway has served as Chief Executive Officer of Optum since May 2025. Previously, Patrick served as Optum Rx's Chief Executive Officer and held numerous leadership roles since joining UnitedHealth Group in February 2020, including service as Chief Executive Officer of Optum Health Care Solutions. Prior to joining UnitedHealth Group, Patrick held prominent senior leadership positions in the private and public sector and clinical settings, including service as Chief Medical Officer and acting administrator at Centers for Medicare and Medicaid Services, and as director of the CMS Innovation Center.
Chris Zaetta has served as Executive Vice President, Chief Legal Officer and Corporate Secretary of UnitedHealth Group since May 2024. Previously, Chris served as Chief Legal Officer of Optum from September 2020 until May 2024. Prior to joining Optum in 2020, Chris was Vice President at Johnson & Johnson, a pharmaceutical company. Chris also held several leadership roles at UnitedHealth Group from May 2011 to September 2019, including Head of Litigation and General Counsel of the organization's government businesses.
Wayne DeVeydt has served as Chief Financial Officer of UnitedHealth Group since September 2025. Prior to joining UnitedHealth Group, Wayne was Managing Director of Bain Capital, a private investment firm, from March 2022 to August 2025. Wayne previously served as Chief Executive Officer, from January 2018 to January 2020, and Executive Chairman of the Board of Directors, from January 2020 to August 2025, of Surgery Partners, an operator of surgical facilities and ancillary services, and Executive Vice President and Chief Financial Officer of Elevance Health (formerly known as Anthem), a health benefits and insurance provider, from 2007 to June 2016.
Kristen Gil, 2007 to 2024: Served in numerous roles with increasing responsibility at Alphabet, Inc., including: Vice President, Business Finance Officer from 2018 to 2023 and Roles within business operations, strategy and finance for Google Search, Maps, Research & AI and Sustainability. 2000 to 2007: General Manager at Marketron International. 1997 to 1999: Management Consultant at McKinsey & Company.
F. William McNabb, 1986 to 2018: Served in numerous roles with increasing responsibility at The Vanguard Group, including: 2008 to 2017: CEO (Chairman from 2008 to 2018) and 1986 to 2008: Various roles including Principal, Managing Director and President. Other Public Directorships: International Business Machines Corp.
Timothy Flynn, 1979 to 2011: Served in numerous roles with increasing responsibility at KPMG, including: Chairman (KPMG International) from 2007 to 2011; CEO (KPMG LLP) from 2005 to 2008; Global Managing Partner, Audit, from 2001 to 2005; Global Managing Partner, Human Resources, from 1998 to 2000. Other Public Directorships: Walmart Inc.
John Noseworthy, 1990 to 2018: Mayo Clinic- 2009 to 2018: President & CEO; 2006 to 2009: Vice Chair of the Mayo Clinic Rochester Board; 1997 to 2006: Chair of the Department of Neurology; 1992 to 2018: Professor in the Department of Neurology at the College of Medicine & Science.
Paul Garcia, 1999 to 2014: Chairman and CEO of Global Payments Inc. 1982 to 1995: President & CEO of NaBanco. Other Public Directorships: Deluxe Corp. and Repay Holdings Corp.
Stephen Hemsley, 1997 to Current: UnitedHealth Group Incorporated- 2025 to Current: Chair and CEO; 2019 to 2025: Non-Executive Chair; 2017 to 2019: Executive Chair; 2006 to 2017: CEO; 1999 to 2014: President; 1997 to 2006: COO. 1974 to 1997: Managing Partner and CFO at Arthur Andersen.
On November 18, 2025, UnitedHealth Group Incorporated announced the appointment of Scott Gottlieb, M.D. to serve as an independent director of the Company, effective immediately. Dr. Gottlieb, 2019 to Current: Senior Fellow at the American Enterprise Institute. 2019 to Current: Special Partner at New Enterprise Associates. 2003 to 2019: Served in numerous roles with increasing responsibility at the U.S. Food & Drug Administration, including: 2017 to 2019: Commissioner; 2005 to 2007: Deputy Commissioner for Medical and Scientific Affairs; 2004: Director of Medical Policy Development; 2003 to 2004: Senior Advisor to the Commissioner for Medical Technology. Other Public Directorships: Pfizer, Inc.; Tempus AI, Inc. and Illumina, Inc.
Tom Roos has served as Senior Vice President and Chief Accounting Officer of UnitedHealth Group since August 2015. Prior to joining UnitedHealth Group, Tom was a Partner at Deloitte & Touche LLP, an independent registered public accounting firm. Tom Roos, who has served as the Company's Chief Accounting Officer since August 2015, will transition from that role to begin serving as Chief Financial Officer of Optum Insight, effective March 2, 2026.
Erin McSweeney has served as Executive Vice President and Chief People Officer of UnitedHealth Group since March 2022. From February 2021 to March 2022, Erin served as chief of staff to UnitedHealth Group's Office of the Chief Executive. From January 2017 to February 2021, she served as Executive Vice President and Chief Human Resources Officer at Optum. Prior to joining UnitedHealth Group, Erin was Executive Vice President and Chief Human Resources Officer for EMC Corporation, an international technology company.
数据来自SEC申报文件(经富途提供)。薪酬为已记录最近财年的报告总薪酬,不仅是基本工资。
暂无评论——快来第一个聊聊 UNH。
登录后参与讨论。